The Effect of Psychosocial Risk Factors on Outcomes After Aortic Valve Replacement.

JACC Cardiovasc Interv

Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

Published: November 2022

AI Article Synopsis

  • Psychosocial risk factors (PSRFs) like substance use, limited cognitive understanding, and low socioeconomic status are linked to poorer surgical outcomes after heart valve replacements, specifically in surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
  • A study involving over 160,000 patients showed that those with PSRFs had higher 30-day mortality and readmission rates after SAVR, whereas for TAVR, readmissions increased but mortality rates remained unchanged.
  • The findings emphasize the need to identify patients with PSRFs before surgery, as this could help healthcare providers choose the most appropriate treatment options, such as TAVR for those with less social support.

Article Abstract

Background: Psychosocial risk factors (PSRFs) have emerged as important nontraditional risk factors that are associated with worse surgical outcomes but have not been well-characterized in valvular disease.

Objectives: This study evaluates the impact of PSRFs on 30-day outcomes following surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).

Methods: All adult patients (≥18 years of age) who underwent isolated TAVR or SAVR in the Nationwide Readmissions Database from 2016 to 2018 were included. Patients were classified as having 0 PSRFs vs ≥1 PSRF. PSRFs included limited cognitive understanding, substance use, psychiatric disease, low socioeconomic status, or uninsured status. Primary outcomes included 30-day mortality, readmission, and composite morbidity (stroke, pulmonary embolus, pacemaker implantation, bleeding complications, acute kidney injury, myocardial infarction, or new atrial fibrillation).

Results: A nationally weighted total of 74,763 SAVR and 87,142 TAVR patients met inclusion criteria. For SAVR, patients with PSRFs had significantly higher 30-day mortality (4.2% vs 3.7%; P = 0.048) and readmissions (13.1% vs 11.3%; P < 0.001), but there was no difference in composite morbidity. For TAVR, patients with PSRFs had significantly higher 30-day readmission (11.7% vs 10.7%; P = 0.012) but no difference in 30-day mortality or composite morbidity. On risk-adjusted analysis, presence of PSRFs was a significant predictor of higher 30-day readmissions following SAVR (adjusted OR: 1.10; 95% CI: 1.02-1.19).

Conclusions: The presence of PSRFs is associated with worse short-term outcomes following SAVR and TAVR, with a more profound impact in SAVR. This study highlights the importance of identifying at-risk patients and suggests that TAVR may be beneficial in patients with less social support.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2022.08.014DOI Listing

Publication Analysis

Top Keywords

30-day mortality
12
composite morbidity
12
higher 30-day
12
risk factors
8
psrfs
8
associated worse
8
aortic valve
8
valve replacement
8
tavr patients
8
patients psrfs
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!